Apoorva Mandavilli

Apoorva Mandavilli's AcademicInfluence.com Rankings

Apoorva Mandavilli

Communications

#3259

World Rank

#4609

Historical Rank

#1431

USA Rank

Journalism

#409

World Rank

#463

Historical Rank

#290

USA Rank

communications Degrees

Download Badge

Communications

Why Is Apoorva Mandavilli Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Apoorva Mandavilli is an American investigative journalist whose work has focused on medical science. During the COVID-19 pandemic, she joined The New York Times as a health and science writer. In the spring of 2019, she was writer-in-residence at the University of Wisconsin, where she joined a panel discussion on vaccine refusal while writing about containing a measles outbreak in Lowell, Massachusetts.

(See a Problem?)

Apoorva Mandavilli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Of mice and men (2006) (465)
Peer review: Trial by Twitter (2011) (127)
A clash of cultures. (2007) (111)
Profile: Marc Tessier-Lavigne (2004) (95)
Visual neuroscience: Look and learn (2006) (48)
News Feature: Asia's big problem (2004) (44)
SARS epidemic unmasks age-old quarantine conundrum (2003) (37)
The amyloid code (2006) (36)
Asia's big problem. (2004) (34)
Appropriate technology: Make anything, anywhere (2006) (31)
Health agency backs use of DDT against malaria (2006) (22)
Virtually incurable TB warns of impending disaster (2007) (15)
News Feature: Hormone in the hot seat (2006) (14)
Nicotine fix (2004) (11)
DDT returns (2006) (11)
Actions speak louder than images (2006) (11)
Profile: Woo-Suk Hwang (2005) (10)
Profile: Hui Zhen Sheng (2006) (8)
When the vaccine causes disease (2007) (8)
One for the money. (2005) (8)
News Feature: Natural-born killers (2003) (7)
The coming epidemic (2005) (7)
India's watchdog: A breath of fresh air (2007) (6)
Struggling to make an impact (2004) (5)
The sunshine cure. (2007) (5)
Reinventing an industry (2007) (4)
Immune response to SARS sets up puzzling paradox (2004) (4)
Scientists seek simple remedies to cloning conundrums (2005) (4)
Spain's ill-conceived project leaves its scientists in the lurch (2006) (4)
News feature: A clash of cultures (2007) (4)
Hormone in the hot seat. (2006) (3)
Marijuana researchers reach for pot of gold (2003) (3)
Mood swings. (2004) (3)
Fertility's new frontier takes shape in the test tube (2003) (2)
Health agency pulls back on 'patronizing' approach to TB treatment (2007) (2)
Profile: Robert Webster (2003) (2)
Profile: David Ho (2004) (2)
News Feature: Mood Swings (2004) (2)
News Feature: One for the money (2005) (2)
Held to ransom (2007) (2)
Gates Foundation looks to fund unconventional health solutions (2008) (2)
Free to fight disease (2008) (2)
AIDS meeting spotlights pills to prevent infection (2006) (2)
Open season (2006) (1)
Jeff Friedman. (2004) (1)
Profile: Yusuke Nakamura (2004) (1)
Profile: Jeff Friedman (2004) (1)
Profile: Thomas Frieden (2006) (1)
Monkey business. (2006) (1)
Contraceptive research pregnant with anticipation (2004) (1)
Nebulous new rules rouse fear and loathing in laboratories (2003) (1)
China launches new molecular medicine institute (2004) (1)
News feature: Trials and tribulations (2007) (1)
News feature: The sunshine cure (2007) (1)
Asian epidemic, abstinence top AIDS meeting agenda (2004) (1)
Indian bioscience: The anti-bureaucrat (2015) (0)
New techniques preserve fertility hope for women (2008) (0)
The lost girls (2015) (0)
Profile: Malik Peiris (2004) (0)
Trials and tribulations. (2007) (0)
Save me from myself! (2006) (0)
News Feature: Screen savers (2005) (0)
Heroin boom fuels AIDS epidemic (2006) (0)
Profile: Patrick Brown (2003) (0)
Straight talk from... Jim Young (2007) (0)
Scientists, NIH in conflict over precious HIV samples (2007) (0)
Natural-born killers. (2003) (0)
SCID trials to remain on the 'bubble' (2003) (0)
Petition aims to maintain cheap drugs (2007) (0)
Profile: Stephen Lewis (2006) (0)
Profile: Michael Malim (2005) (0)
Leukaemia (2013) (0)
Don't rush your vaccines (2007) (0)
Screen savers. (2005) (0)
Patrick Brown. (2003) (0)
Unreasonable doubt (2007) (0)
Profile: Dominique Toran-Allerand (2005) (0)
Public Misinformation and Science Communication in Times of Public Health Crises. (2022) (0)
Chemical geneticists unify their data. (2002) (0)
AIDS care ignores children (2004) (0)
Troubled times force old pharma to learn new tricks (2003) (0)
Dennis Burton (2003) (0)
Microbiology: Straight from the gut (2008) (0)
Premature medication (2006) (0)
Gates Foundation looks to fund unconventional health solutions. (2008) (0)
Big issues from a small child (2007) (0)
News Feature: Monkey business (2006) (0)
Glue grants to tackle sticky issue (2001) (0)
Risky business (2007) (0)
Profile: Yoshihiro Kawaoka (2006) (0)
Yoshihiro Kawaoka. (2006) (0)
Dominique Toran-Allerand. (2005) (0)
First genome study of anticarcinogen bears fruit (2002) (0)
Profile: Peter Doherty (2007) (0)
Superfast TB test slashes waiting time (2010) (0)
Scientific openness faces reality check (2003) (0)
AIDS epidemic set to escalate in Asia (2004) (0)
Struggling to make an impact : Malaria (2004) (0)
Finally: hints of HIV turnaround in South Africa (2006) (0)
News In Brief (2006) (0)
Straight talk from... James Love (2007) (0)
Yusuke Nakamura. (2004) (0)
The new drugs use a totally different mechanism than most would-be treatments. (2012) (0)
Profile: Wafaa El-Sadr (2007) (0)

This paper list is powered by the following services:

Other Resources About Apoorva Mandavilli

What Schools Are Affiliated With Apoorva Mandavilli?

Apoorva Mandavilli is affiliated with the following schools: